%0 Generic
%A Balmana, J.
%A Pascual, T.
%A Llop-Guevara, A.
%A Tolosa, P.
%A Blancas Lopez-Barajas, I.
%A Perez Lopez, M. E.
%A Adamo, B.
%A Teruel-Garcia, I.
%A Ponce, J.
%A Gonzalez-Cordero, M.
%A Vinas Villaro, G.
%A Lema Roso, L.
%A Salvador Bofill, F. J.
%A Martinez, M. T. M.
%A Guerrero, A. N. E.
%A Prat, A.
%A Serra Elizalde, V.
%T SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial
%D 2022
%@ 0923-7534
%U http://hdl.handle.net/10668/21898
%~